Data di Pubblicazione:
2016
Abstract:
Ovarian cancer represents one of the major form of cancer in women in the western world and its silent nature leads to a late clinical manifestation at advanced stage in many patients. Therefore the role of imaging techniques is very important for the correct management of these patients. In the present review, the role of 18F-FDG-PET/CT in the different clinical settings is presented and a comparison with other imaging modalities and serum biomarker CA-125 are discussed.
Tipologia CRIS:
1.1.3. Articolo in Rivista - Editorial, Comment, Reply
Keywords:
Biomarkers, Tumor; Female; Humans; Neoplasm Staging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Fluorodeoxyglucose F18
Elenco autori:
Mapelli, Paola; Incerti, Elena; Fallanca, Federico; Gianolli, Luigi; Picchio, Maria
Link alla scheda completa:
Pubblicato in: